Copyright Reports & Markets. All rights reserved.

Global Argatroban Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Argatroban Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Argatroban Powder
      • 1.2.2 Argatroban Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Heparin-induced thrombocytopenia (HIT)
      • 1.3.2 Percutaneous Coronary Intervention
      • 1.3.3 Cerebral arterial thrombosis
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Pfizer, Inc
      • 2.1.1 Business Overview
      • 2.1.2 Argatroban Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 SANDOZ
      • 2.2.1 Business Overview
      • 2.2.2 Argatroban Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 GlaxoSmithKline Plc
      • 2.3.1 Business Overview
      • 2.3.2 Argatroban Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 fresenius-kabi
      • 2.4.1 Business Overview
      • 2.4.2 Argatroban Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Eagle Pharmaceuticals, Inc
      • 2.5.1 Business Overview
      • 2.5.2 Argatroban Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Mitsubishi Tanabe Pharma
      • 2.6.1 Business Overview
      • 2.6.2 Argatroban Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Teva Pharmaceutical Industries Ltd
      • 2.7.1 Business Overview
      • 2.7.2 Argatroban Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 WEST-WARD,INC
      • 2.8.1 Business Overview
      • 2.8.2 Argatroban Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Argatroban Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Argatroban Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Argatroban Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Argatroban Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Argatroban Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Argatroban Market Analysis by Regions

    • 4.1 Global Argatroban Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Argatroban Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Argatroban Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Argatroban Sales and Growth Rate (2014-2019)
    • 4.3 Europe Argatroban Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Argatroban Sales and Growth Rate (2014-2019)
    • 4.5 South America Argatroban Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Argatroban Sales and Growth Rate (2014-2019)

    5 North America Argatroban by Country

    • 5.1 North America Argatroban Sales, Revenue and Market Share by Country
      • 5.1.1 North America Argatroban Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Argatroban Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Argatroban Sales and Growth Rate (2014-2019)
    • 5.3 Canada Argatroban Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Argatroban Sales and Growth Rate (2014-2019)

    6 Europe Argatroban by Country

    • 6.1 Europe Argatroban Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Argatroban Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Argatroban Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Argatroban Sales and Growth Rate (2014-2019)
    • 6.3 UK Argatroban Sales and Growth Rate (2014-2019)
    • 6.4 France Argatroban Sales and Growth Rate (2014-2019)
    • 6.5 Russia Argatroban Sales and Growth Rate (2014-2019)
    • 6.6 Italy Argatroban Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Argatroban by Country

    • 7.1 Asia-Pacific Argatroban Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Argatroban Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Argatroban Revenue and Market Share by Country (2014-2019)
    • 7.2 China Argatroban Sales and Growth Rate (2014-2019)
    • 7.3 Japan Argatroban Sales and Growth Rate (2014-2019)
    • 7.4 Korea Argatroban Sales and Growth Rate (2014-2019)
    • 7.5 India Argatroban Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Argatroban Sales and Growth Rate (2014-2019)

    8 South America Argatroban by Country

    • 8.1 South America Argatroban Sales, Revenue and Market Share by Country
      • 8.1.1 South America Argatroban Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Argatroban Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Argatroban Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Argatroban Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Argatroban Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Argatroban by Countries

    • 9.1 Middle East and Africa Argatroban Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Argatroban Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Argatroban Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Argatroban Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Argatroban Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Argatroban Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Argatroban Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Argatroban Sales and Growth Rate (2014-2019)

    10 Global Argatroban Market Segment by Type

    • 10.1 Global Argatroban Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Argatroban Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Argatroban Revenue and Market Share by Type (2014-2019)
    • 10.2 Argatroban Powder Sales Growth and Price
      • 10.2.1 Global Argatroban Powder Sales Growth (2014-2019)
      • 10.2.2 Global Argatroban Powder Price (2014-2019)
    • 10.3 Argatroban Injection Sales Growth and Price
      • 10.3.1 Global Argatroban Injection Sales Growth (2014-2019)
      • 10.3.2 Global Argatroban Injection Price (2014-2019)

    11 Global Argatroban Market Segment by Application

    • 11.1 Global Argatroban Sales Market Share by Application (2014-2019)
    • 11.2 Heparin-induced thrombocytopenia (HIT) Sales Growth (2014-2019)
    • 11.3 Percutaneous Coronary Intervention Sales Growth (2014-2019)
    • 11.4 Cerebral arterial thrombosis Sales Growth (2014-2019)

    12 Argatroban Market Forecast (2019-2024)

    • 12.1 Global Argatroban Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Argatroban Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Argatroban Market Forecast (2019-2024)
      • 12.2.2 Europe Argatroban Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Argatroban Market Forecast (2019-2024)
      • 12.2.4 South America Argatroban Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Argatroban Market Forecast (2019-2024)
    • 12.3 Argatroban Market Forecast by Type (2019-2024)
      • 12.3.1 Global Argatroban Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Argatroban Market Share Forecast by Type (2019-2024)
    • 12.4 Argatroban Market Forecast by Application (2019-2024)
      • 12.4.1 Global Argatroban Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Argatroban Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

      Scope of the Report:
      In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
      from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.

      Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.

      The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.

      China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.

      Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.

      The worldwide market for Argatroban is expected to grow at a CAGR of roughly -14.9% over the next five years, will reach 32 million US$ in 2024, from 84 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Argatroban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Pfizer, Inc
      SANDOZ
      GlaxoSmithKline Plc
      fresenius-kabi
      Eagle Pharmaceuticals, Inc
      Mitsubishi Tanabe Pharma
      Teva Pharmaceutical Industries Ltd
      WEST-WARD,INC

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Argatroban Powder
      Argatroban Injection

      Market Segment by Applications, can be divided into
      Heparin-induced thrombocytopenia (HIT)
      Percutaneous Coronary Intervention
      Cerebral arterial thrombosis

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Argatroban product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Argatroban, with price, sales, revenue and global market share of Argatroban in 2017 and 2018.
      Chapter 3, the Argatroban competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Argatroban breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Argatroban sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now